View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

Congresswoman Diana DeGette Discusses Path 2 Cures Initiative at DPharm


  • September 24, 2014

  • We were honored to welcome Congresswoman Diana DeGette as our Keynote speaker at DPharm on September 12, 2014. Rep. DeGette is helping lead a landmark initiative dedicated to creating a path to 21st century cures. For the first time ever, Congress is taking a comprehensive look at what can be done to accelerate the pace of cures in America. They are looking at the entire spectrum, from discovery and development to delivery of medicines. Rep. DeGette gave the DPharm audience of more than 300 life science industry professionals an update on the progress of the initiative and generously answered many audience questions. The genuine support from Rep. DeGette’s message could be felt by the audience throughout the conference venue. The coming together of true collaboration from all walks of the pharma/biotech industry, including non-profits, academia and more government initiatives, is truly inspiring drug developers.
    See more at: http://energycommerce.house.gov/cures#sthash.Kw7FVj3d.dpuf


    About U.S. Rep. DeGette
    Chief Deputy Whip Diana DeGette is serving her 9th term in Congress as Representative for the First District of Colorado. As a member of the powerful Committee on Energy and Commerce, an exclusive congressional committee with vast jurisdiction over health care, trade, business, technology, food safety, and consumer protection, she is one of the leading voices in the health care debate in this country. She also serves as the Ranking Member of the Subcommittee on Oversight and Investigations, which conducts the oversight of, and investigations into, issues falling under the jurisdiction of the full committee. As a member of the Democratic leadership, she played a vital role in the reauthorization of the Children’s Health Insurance Program, has fought for tough food safety legislation, and was a key player in crafting a comprehensive consumer product safety bill.

    U.S. Rep. DeGette is also the chief architect of legislation to expand stem cell research, which has been passed twice with broad, bipartisan support in Congress.